![]() |
市場調查報告書
商品編碼
1959903
自主手術機器人市場-全球產業規模、佔有率、趨勢、機會、預測:按產品類型、應用、最終用戶、地區和競爭對手分類,2021-2031年Autonomous Surgical Robotics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Application, By End-User (Hospitals, Ambulatory Surgery Centers, Others), By Region & Competition, 2021-2031F |
||||||
全球自主手術機器人市場預計將從 2025 年的 22.3 億美元大幅成長至 2031 年的 45.3 億美元,複合年成長率達 12.54%。
該領域涵蓋利用人工智慧進行術前策略制定和即時指導的智慧機器人平台,這些平台能夠以不同程度的自主性執行手術任務。推動該領域成長的主要因素是需要手術治療的慢性疾病的普遍存在,以及對能夠加速患者康復的微創手術技術的強勁需求。此外,全球醫療專業人員短缺也促使人們採用自動化技術來提高手術精度。國際機器人聯合會的數據也支持這一趨勢,數據顯示,到2024年,醫療機器人的銷售將激增91%,達到約16,700台。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 22.3億美元 |
| 市場規模:2031年 | 45.3億美元 |
| 複合年成長率:2026-2031年 | 12.54% |
| 成長最快的細分市場 | 機器人系統 |
| 最大的市場 | 北美洲 |
然而,由於法規環境複雜且專注於問責制和安全,該市場面臨許多障礙。隨著系統朝自主決策方向發展,操作失誤和不良病人後果的責任認定也引發了棘手的法律挑戰。除了法規結構尚不明確之外,臨床檢驗和認證所需的大量資金也嚴重阻礙了這些先進外科技術的廣泛商業化和應用。
推動自主手術機器人普及應用的主要動力之一是熟練外科醫生和醫療專業人員的嚴重短缺。隨著專業醫療人員數量與需要複雜治療的患者數量之間的差距日益擴大,醫院正依靠機器人系統來補充人類的能力並簡化工作流程。這些自動化平台將使更少的醫生能夠處理更多的病例,同時透過減輕操作者的體力負擔和規範手術質量,在不影響安全性的前提下完成更多手術。根據美國醫學院協會 (AAMC) 2024 年 3 月的報告,預計到 2036 年,美國將面臨多達 19,900 名外科醫生的缺口,這凸顯了採用技術解決方案最大限度地提高手術能力的緊迫性。
同時,對微創手術技術的需求不斷成長,正在重塑市場格局。隨著患者和醫療機構尋求創傷最小、恢復更快的手術方式,機器人系統能夠以比傳統腹腔鏡手術更高的精度完成這些精細手術,從而推動了其在泌尿系統、婦科和普通外科領域的應用。這種需求也體現在主要企業的快速成長。直覺外科公司(Intuitive Surgical)預計,到2024年底,其達文西手術在全球範圍內將成長18%,這表明該技術在臨床實踐中得到了廣泛認可。此外,新興競爭對手也不斷拓展其全球業務,CMR Surgica公司預計在2024年將迎來一個里程碑,其Versius系統在全球累積完成的手術數量將超過2萬例。
全球自主手術機器人市場面臨的主要限制阻礙因素是複雜的責任和安全保障監管環境。隨著機器人系統朝向自主決策方向發展,現有的法律體制難以明確界定操作人員、醫療機構和設備製造商在發生不利事件時的責任。這種法律上的模糊性導致必須進行嚴格的安全檢驗和大規模臨床試驗,從而顯著延長了產品開發週期。因此,製造商面臨更長的監管核准時間、自主功能推出延遲以及阻礙投資的商業不確定性。
此外,滿足這些嚴格標準帶來的經濟負擔提高了創新開發商的進入門檻,阻礙了市場擴張。安全認證所需的大量資源往往會擠佔技術研發資金,從而限制了產品改進的速度。據歐洲醫療技術協會(MedTech Europe)稱,與先前的指令相比,到2024年,新法規結構下的認證和維修成本將增加高達100%。遵循成本的急劇上升降低了新業務的財務可行性,並減緩了自主技術在外科手術市場的整體普及速度。
將人工智慧 (AI) 應用於即時決策支援,正從根本上改變外科手術格局,將機器人系統轉變為智慧的、數據驅動的合作夥伴。產業領導者正積極擴展其數位化生態系統,以整合機器學習演算法,從而實現術中導航、手術影片分析以及手術流程的即時最佳化。這項技術進步將能夠預測關鍵解剖結構的識別並實現手術技術的標準化,從而顯著降低患者預後的差異性。例如,美敦力公司於 2025 年 9 月宣布,已將其位於倫敦的數位化部門的員工人數增加了一倍,部署了 200 多名專家,以加速開發這些先進的人工智慧和數位化能力。
同時,單孔和多孔機器人平台的普及正在使市場多元化,以適應更廣泛的臨床適應症和醫院環境。製造商正摒棄千篇一律的解決方案,轉而推出專用系統,例如用於深部手術的單孔平台和專為複雜普通外科手術設計的高性能多孔系統。這種策略性細分使醫療機構能夠採用與其病例特徵精準匹配的技術,從而加速其在各個外科領域的應用。為了支持這一趨勢,Intuitive Surgical 於 2025 年 1 月宣布,其在上年度中已在全球安裝了 362 套新型「達文西 5」多孔系統。
The Global Autonomous Surgical Robotics Market is projected to expand significantly, rising from USD 2.23 Billion in 2025 to USD 4.53 Billion by 2031, reflecting a compound annual growth rate of 12.54%. This sector comprises intelligent robotic platforms that perform surgical tasks with varying levels of autonomy, leveraging artificial intelligence for both pre-operative strategy and real-time guidance. Growth is largely fueled by the prevalence of chronic conditions requiring surgery and a strong preference for minimally invasive techniques that speed up patient recovery. Additionally, the global scarcity of medical specialists is driving the uptake of automation to enhance surgical precision, a trend evidenced by International Federation of Robotics data showing a 91% surge in medical robot sales to nearly 16,700 units in 2024.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 2.23 Billion |
| Market Size 2031 | USD 4.53 Billion |
| CAGR 2026-2031 | 12.54% |
| Fastest Growing Segment | Robotic Systems |
| Largest Market | North America |
However, the market faces significant hurdles due to a complex regulatory environment focused on liability and safety assurance. As systems move toward autonomous decision-making, difficult legal questions arise regarding accountability for operational errors or adverse patient outcomes. These undefined regulatory frameworks, coupled with the immense financial resources needed for clinical validation and certification, create substantial obstacles to the widespread commercialization and adoption of these advanced surgical technologies.
Market Driver
A primary catalyst accelerating the deployment of autonomous surgical robotics is the critical shortage of skilled surgeons and healthcare personnel. As the gap widens between the supply of specialized professionals and the volume of patients requiring complex care, hospitals are relying on robotic systems to augment human capabilities and streamline workflows. These automated platforms reduce physical strain on operators and standardize procedure quality, allowing fewer surgeons to manage higher caseloads without compromising safety. According to a March 2024 report by the Association of American Medical Colleges, the United States is projected to face a shortfall of up to 19,900 surgeons by 2036, highlighting the urgent need for technological solutions that maximize surgical throughput.
Simultaneously, the rising preference for minimally invasive surgical techniques is reshaping the market, as patients and providers seek procedures that minimize trauma and accelerate recovery. Robotic systems facilitate these delicate operations with greater precision than manual laparoscopy, driving widespread adoption across urology, gynecology, and general surgery. This demand is reflected in the rapid growth of major industry players; Intuitive Surgical recorded an 18% increase in worldwide da Vinci procedure volume in late 2024, signaling robust clinical acceptance. Furthermore, emerging competitors are expanding their global footprint, with CMR Surgical celebrating a milestone of over 20,000 surgical cases completed globally using its Versius system in 2024.
Market Challenge
The complex regulatory landscape regarding liability and safety assurance acts as a major constraint on the Global Autonomous Surgical Robotics Market. As robotic systems evolve toward autonomous decision-making, existing legal frameworks struggle to clearly define accountability among human operators, medical institutions, and equipment manufacturers during adverse events. This legal ambiguity necessitates rigorous safety validation and extensive clinical trials, which significantly prolong the product development lifecycle. Consequently, manufacturers face extended timelines for regulatory approval, delaying the introduction of autonomous capabilities and creating operational uncertainty that deters investment.
Moreover, the financial burden associated with meeting these stringent standards hampers market expansion by raising barriers to entry for innovative developers. The substantial resources required for safety certification often divert capital away from technical research, limiting the speed of product iteration. According to MedTech Europe, certification and maintenance costs under the new regulatory framework escalated by up to 100% in 2024 compared to previous directives. This sharp increase in compliance expenditures reduces the financial viability of new ventures and slows the overall penetration of autonomous technologies in the surgical market.
Market Trends
The integration of Artificial Intelligence for real-time decision support is fundamentally altering the surgical landscape by transforming robotic systems into intelligent, data-driven partners. Industry leaders are aggressively expanding their digital ecosystems to embed machine learning algorithms that provide intraoperative guidance, analyze surgical video, and optimize procedural workflows in real-time. This technological evolution allows for the predictive identification of critical anatomy and the standardization of surgical techniques, significantly reducing variability in patient outcomes. For instance, Medtronic announced in September 2025 that it had doubled its London-based digital workforce to over 200 specialists specifically to accelerate the development of these advanced AI and digital capabilities.
Concurrently, the proliferation of single-port and multi-port robotic platforms is diversifying the market to address a wider range of clinical indications and hospital environments. Manufacturers are moving beyond one-size-fits-all solutions by launching specialized systems, such as single-port platforms for deep-access surgery and high-performance multi-port systems designed for complex general procedures. This strategic segmentation enables healthcare facilities to adopt technology that precisely matches their case mix, driving broader utilization across various surgical disciplines. Validating this trend, Intuitive Surgical reported in January 2025 that it successfully placed 362 units of its new da Vinci 5 multiport system globally during the previous year.
Report Scope
In this report, the Global Autonomous Surgical Robotics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Autonomous Surgical Robotics Market.
Global Autonomous Surgical Robotics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: